Evidence map›Paper›PMID 35360075›Full record

ReviewFrontiers in endocrinology2022

The Implications of Bone Marrow Adipose Tissue on Inflammaging.

Nicole Aaron, Samantha Costa, Clifford J Rosen, Li Qiang

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
18.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Review
  3. Aging-Driven Inter-Organ Crosstalk in Postmenopausal Osteoporosis: From Immunometabolic Drift to Multisystem Frailty.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Nicole AaronNaomi Berrie Diabetes Center, Columbia University, New York, NY, United States.
Samantha CostaCenter for Clinical and Translational Research, Maine Medical Center Research Institute, Scarborough, ME, United States.
Clifford J RosenCenter for Clinical and Translational Research, Maine Medical Center Research Institute, Scarborough, ME, United States.
Li QiangNaomi Berrie Diabetes Center, Columbia University, New York, NY, United States.
Columbia University · USMaine Medical Center Research Institute · USUniversity of Maine · US

Funding

Targeting FSH for the Therapy of Osteoporosis, Obesity and NeurodegenerationU19AG060917 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Mone Zaidi · 2019 to 2026
$29.0M
Interdisciplinary Study of Marrow Adiposity, Mineral Metabolism & Energy BalanceR24DK092759 · NIDDK · MAINEHEALTH · PI HOROWITZ, MARK C, MACDOUGALD, ORMOND A · 2011 to 2019
$13.0M
PPARgamma Deacetylation in the Restoration of Metabolic HomeostasisR01DK112943 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI QIANG, LI · 2018 to 2022
$2.4M
Preclinical Validation of PPARg Acetylation Inhibitors for Diabetes Prevention and TreatmentR01DK128848 · NIDDK · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI WANG, WEIDONG · 2021 to 2025
$2.4M
Mechanisms by which adipocytes adapt to cool environmental temperaturesR01DK121759 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MACDOUGALD, ORMOND A · 2020 to 2024
$2.0M
Adipsin from bone marrow fat as a regulator of bone remodelingF31DK124926 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI AARON, NICOLE · 2020 to 2021
$89k
NIA NIH HHS U19 AG060917NIDDK NIH HHS F31 DK124926NIDDK NIH HHS R01 DK112943NIDDK NIH HHS R01 DK121759NIDDK NIH HHS R01 DK128848NIDDK NIH HHS R24 DK092759
6 · The paper itself

Abstract

Once considered an inert filler of the bone cavity, bone marrow adipose tissue (BMAT) is now regarded as a metabolically active organ that plays versatile roles in endocrine function, hematopoiesis, bone homeostasis and metabolism, and, potentially, energy conservation. While the regulation of BMAT is inadequately understood, it is recognized as a unique and dynamic fat depot that is distinct from peripheral fat. As we age, bone marrow adipocytes (BMAds) accumulate throughout the bone marrow (BM) milieu to influence the microenvironment. This process is conceivably signaled by the secretion of adipocyte-derived factors including pro-inflammatory cytokines and adipokines. Adipokines participate in the development of a chronic state of low-grade systemic inflammation (inflammaging), which trigger changes in the immune system that are characterized by declining fidelity and efficiency and cause an imbalance between pro-inflammatory and anti-inflammatory networks. In this review, we discuss the local effects of BMAT on bone homeostasis and the hematopoietic niche, age-related inflammatory changes associated with BMAT accrual, and the downstream effect on endocrine function, energy expenditure, and metabolism. Furthermore, we address therapeutic strategies to prevent BMAT accumulation and associated dysfunction during aging. In sum, BMAT is emerging as a critical player in aging and its explicit characterization still requires further research.

Indexed as

Adipose TissueAgingBone MarrowAdipocytesAdipokinesBone and BonesHumansInflammationAdipokinesagingbone marrow adipocytesbone marrow adipose tissue (BMAT)inflammaginginflammation

Identifiers

PMID35360075
PMCPMC8962663
OpenAlexW4220735076

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.